04/30/2026
GLP-1 receptor agonists, originally developed for Type 2 diabetes, are showing promise in alleviating joint pain and reducing inflammation for those living with arthritis.
https://ow.ly/wpwG50YRRNW
Emerging research suggests popular GLP-1 weight loss drugs – like Ozempic, Wegovy and Mounjaro – may ease arthritis and joint pain by triggering weight loss and reducing systemic inflammation.